Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance-Reference-Cited by-同舟云学术

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance

Published:2017-06-09 Issue:3 Volume:182 Page:437-440
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Barraco Daniela¹^ORCID,Cerquozzi Sonia¹,Hanson Curtis A.²,Ketterling Rhett P³,Pardanani Animesh D.¹,Gangat Naseema¹,Tefferi Ayalew¹

Affiliation:

1. Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester MN USA

2. Division of Hematopathology; Mayo Clinic; Rochester MN USA

3. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14798/fullpdf

Reference10 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (vol 127, pg 2391, 2016);Arber;Blood,2016

2. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients;Caramazza;Leukemia,2011

3. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates;Gangat;European Journal of Haematology,2008

4. Significance of cytogenetic abnormalities in patients with polycythemia vera;Sever;Leukaemia & Lymphoma,2013

5. Cytogenetic nomenclature: changes in the ISCN 2013 compared to the 2009 edition;Simons;Cytogenetic and Genome Research,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving landscape of polycythemia vera therapies;Expert Opinion on Pharmacotherapy;2024-07-23

2. Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia;American Journal of Hematology;2024-06-06

3. Erythrocytosis: Diagnosis and investigation;International Journal of Laboratory Hematology;2024-05

4. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

5. Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-06-26